Risk factors related to persistent airflow obstruction in severe asthma in Chinese Han population.

OBJECTIVE To explore the significance of assessing persistent airway obstruction (PAO) in asthma patients by airway wall remodeling with bronchoscopy, high-resolution computed tomography (HRCT), and biological markers in the induced sputum and serum, exhaled nitric oxide (FENO), and lung function. METHODS The study was conducted in 119 patients with PAO and 125 patients with reversible airway obstruction (RAO). Endobronchial biopsy specimens were analyzed for airway smooth muscle (ASM) area, and reticular basement membrane (RBM) thickness. Airway thickness was also measured by HRCT scanning. Levels of matrix metalloproteases-9 (MMP-9), metalloproteinase 33 (ADAM33), and vascular endothelial growth factor (VEGF) were measured in the induced sputum and serum by enzyme linked immunosorbent assay. RESULT PAO was associated with longer disease duration, absence of atopy and rhinitis, and larger ASM area (SMA%) (15.83%±2.32% [n=9] vs. 8.0%±1.68% [n=7], P=0.02), thicker RBM (16.27±2.32 μm [n=9] vs. 8.71±2.41 μm [n=7], P=0.042); No differences in any of the biomarker molecules measured in airway thickness in HRCT, sputum and blood individually between groups were found. CONCLUSION Severe asthma patients with longer disease duration and the absence of atopy and rhinitis are more likely to develop PAO in Chines Han population. PAO patients have increased ASM area and RBM thickness appear to be valuable in the evaluation of airway remodeling in asthma patients in Chinese Han population.

[1]  Sang-Heon Cho,et al.  Smoking, longer disease duration and absence of rhinosinusitis are related to fixed airway obstruction in Koreans with severe asthma: findings from the COREA study , 2011, Respiratory research.

[2]  Chun-Tao Liu,et al.  Effects of formoterol-budesonide on airway remodeling in patients with moderate asthma , 2011, Acta Pharmacologica Sinica.

[3]  C. Lemière,et al.  Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction. , 2009, The Journal of allergy and clinical immunology.

[4]  G. Viegi,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 * , 2008, Allergy.

[5]  S. Wenzel,et al.  Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. , 2007, Chest.

[6]  A. Foresi,et al.  Vascular endothelial growth factor up‐regulation and bronchial wall remodelling in asthma , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  M. Ennis,et al.  Children with stable asthma have reduced airway matrix metalloproteinase‐9 and matrix metalloproteinase‐9/tissue inhibitor of metalloproteinase‐1 ratio , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[8]  C. Bucca,et al.  Asthma severity and medical resource utilisation , 2004, European Respiratory Journal.

[9]  M. Aubier,et al.  Airway structural alterations selectively associated with severe asthma. , 2003, American journal of respiratory and critical care medicine.

[10]  D. Postma,et al.  Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. , 2003, Thorax.

[11]  F. Rasmussen,et al.  Risk factors for hospital admission for asthma from childhood to young adulthood: a longitudinal population study. , 2002, The Journal of allergy and clinical immunology.

[12]  A. Zwinderman,et al.  Factors associated with persistent airflow limitation in severe asthma. , 2001, American journal of respiratory and critical care medicine.

[13]  V. Popa.  ATS guidelines for methacholine and exercise challenge testing. , 2001, American journal of respiratory and critical care medicine.

[14]  T. Koelmeyer,et al.  The effect of age and duration of disease on airway structure in fatal asthma. , 2000, American journal of respiratory and critical care medicine.

[15]  S. Spector,et al.  Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. , 2000, American journal of respiratory and critical care medicine.

[16]  Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide in Adults and Children — 1999 , 1999 .

[17]  J. Bousquet,et al.  Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. , 1998, American journal of respiratory and critical care medicine.

[18]  I. Pavord,et al.  The use of induced sputum to investigate airway inflammation. , 1997, Thorax.

[19]  L. Boulet,et al.  Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction. , 1995, American journal of respiratory and critical care medicine.

[20]  S. Codd,et al.  Physical determinants of bronchial mucosal folding. , 1994, Journal of applied physiology.